Janux Therapeutics Inc Asset Turnover Ratio (JANX), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Janux Therapeutics Inc   (NASDAQ: JANX)
 

Janux Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Janux Therapeutics Inc asset turnover ratio, the ability of Janux Therapeutics Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.02 in the second quarter (Jun 30 2026), JANX's balance sheet remain strong.

Within sector Janux Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

JANX Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 0.02 % -0.49 % -4.02 % 48.72 % 50.88 %
Y / Y Revenue Change - - - 2177.9 % -
Asset Turnover Ratio (TTM) 0.02 0.01 - 0.01 -
JANX's Total Ranking # # # # #
Seq. Asset Change -1.25 % 2.66 % -0.48 % -0.87 % -1.75 %
Seq. Revenue Change 175.03 % - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




JANX Company Profile • Back to JANX Efficiency Comparisons • Compare JANX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Ocugen Inc   0.06 $ 4.580  Millions$ 70.556  Millions
Metagenomi Therapeutics Inc   0.06 $ 13.561  Millions$ 209.924  Millions
Nurix Therapeutics Inc   0.06 $ 36.766  Millions$ 595.569  Millions
EBR Systems, Inc.  0.06 $ 6.446  Millions$ 105.295  Millions
Caribou Biosciences Inc   0.06 $ 10.035  Millions$ 165.531  Millions
Grail Inc   0.06 $ 165.263  Millions$ 2,792.551  Millions
Ispecimen inc   0.06 $ 0.466  Millions$ 8.133  Millions
Nexalin Technology Inc   0.05 $ 0.217  Millions$ 4.115  Millions
Prophase Labs Inc   0.05 $ 3.150  Millions$ 60.428  Millions
Alector Inc   0.05 $ 13.863  Millions$ 267.823  Millions
Seer Inc   0.05 $ 14.377  Millions$ 283.365  Millions
Abcellera Biologics Inc   0.05 $ 66.174  Millions$ 1,331.907  Millions
Monte Rosa Therapeutics Inc   0.05 $ 28.727  Millions$ 584.022  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.670  Millions$ 34.891  Millions
Dar Bioscience Inc   0.05 $ 1.345  Millions$ 28.355  Millions
Nakamoto Inc   0.05 $ 28.962  Millions$ 616.576  Millions
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Aclaris Therapeutics Inc   0.05 $ 8.219  Millions$ 178.602  Millions
Cytokinetics Incorporated  0.04 $ 67.670  Millions$ 1,514.781  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 203.358  Millions
Camp4 Therapeutics Corporation  0.04 $ 4.216  Millions$ 100.772  Millions
Recursion Pharmaceuticals Inc   0.04 $ 54.855  Millions$ 1,356.462  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Kyntra Bio Inc   0.04 $ 4.617  Millions$ 116.829  Millions
X4 Pharmaceuticals Inc  0.04 $ 9.441  Millions$ 244.340  Millions
Blue Water Vaccines Inc  0.03 $ 0.646  Millions$ 18.966  Millions
Crinetics Pharmaceuticals Inc   0.03 $ 42.156  Millions$ 1,261.374  Millions
Pluri Inc   0.03 $ 1.016  Millions$ 30.822  Millions
Tscan Therapeutics Inc   0.03 $ 7.111  Millions$ 216.114  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.